Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Enter the anti-CRISPR protein AcrVIB1, a promising inhibitor whose exact function has remained a mystery—until now. A ...

"EditCo Bio secures access to Promega’s technologies in licensing deal" was originally created and published by ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

Using a novel method that gives a readout of which proteins are in specific locations within cells, UT Southwestern Medical ...

The medical promise of CRISPR gene editing can be seen most easily in current research on oral cancer, which affects more than 50,000 Americans every year. An increasing challenge in the treatment ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

“We used a genome-wide CRISPR interference screen to silence each of the protein-coding human genes in cells and identified ...